Increase access to hepatitis C (HCV) testing and care in drug services- a toolkit

People who inject drugs (PWID) are a key population for the elimination of hepatitis C in Europe, and increasing their access to HCV testing and care is a goal in European and national hepatitis C policies. Despite this, HCV testing remains low among people who inject drugs and effective approaches to promote testing as the first element of a cascade of care are particularly needed.

EMCDDA has put together a toolkit to increase access to testing and care in drug services.

The toolkit includes:

• Assessing the needs: a step-by-step guide
• Hepatitis C: new models of care for drug services
• Knowledge questionnaire and other hepatitis materials
• Further resources to support policymaking and practice